Fingerprint
Dive into the research topics where Anthony Martinez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants & Projects
- 2 Finished
-
Interdisciplinary Substance Use Disorder Fellowship Training Program
Abdelsayed, S. (PI), Elliott, F. (PI), Doscher, T. (CoI), Kahn, L. (CoI), Linkie, C. (CoI) & Martinez, A. (CoI)
Health Resources and Services Admin
07/1/23 → 06/30/25
Project: Research
-
A Phase III open-label clinical trial to study the efficacy and safety of the combination regimen of MK-5172/MK-8742 in treatment-naive subjects with chronic HCV GT1, GT4, GT5, and GT6 infection who are on opiate substitution therapy
Talal, A. (PI) & Martinez, A. (CoI)
Merck Sharp and Dohme Limited Liability Corporation
08/27/14 → 02/26/20
Project: Research
-
Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs
Sulkowski, M. S., Martinez, A., Tyson, G. L., Scholz, K., Franco, R. A., Kohli, A., Julius, S. F., Deming, P., Fink, S. A., Lynch, K., Roytman, M., Stainbrook, T. R., Turner, M. D., Viera-Briggs, M. & Ramers, C. B., Jun 2024, In: Journal of Viral Hepatitis. 31, 6, p. 342-356 15 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations
Mukherjee, D., Collins, M., Dylla, D. E., Kaur, J., Semizarov, D., Martinez, A., Conway, B., Khan, T. & Mostafa, N. M., Aug 2023, In: Infectious Diseases and Therapy. 12, 8, p. 2057-2070 14 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients
Reau, N., Cheng, W. H., Shao, Q., Marx, S. E., Brooks, H. & Martinez, A., Jul 2023, In: Infectious Diseases and Therapy. 12, 7, p. 1849-1860 12 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021
Martinez, A., Khan, T., Dylla, D. E., Marcinak, J., Collins, M., Saget, B. & Conway, B., Dec 2023, In: Harm Reduction Journal. 20, 1, 142.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study
Martinez, A., Cheng, W. H., Marx, S. E., Manthena, S., Dylla, D. E., Wilson, L. & Thomas, E., Aug 2023, In: Advances in Therapy. 40, 8, p. 3465-3477 13 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations